- Issuer
- Tema
- Inception Date
- Nov 20, 2023
- Region
- Global (Broad)
- Category
- Health & Biotech Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- No Index (Active)
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Mid-Cap
- Asset Class Style
- Growth
- Assets Under Management
- $52M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
HRTS Performance Chart
Tema Obesity & Cardiometabolic ETF (HRTS) is down 6.2% since the beginning of the year. HRTS is currently trading at $33 per share.
Loading charts...
Returns By Period
Tema Obesity & Cardiometabolic ETF (HRTS) has returned -6.17% so far this year and 20.02% over the past 12 months.
Tema Obesity & Cardiometabolic ETF
- 1D
- -2.01%
- 1M
- -1.29%
- YTD
- -6.17%
- 6M
- -4.81%
- 1Y
- 20.02%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
HRTS Monthly Returns History
Based on dividend-adjusted daily data since Nov 21, 2023, HRTS's average daily return is +0.05%, while the average monthly return is +0.90%. At this rate, an investment would double in approximately 6.4 years.
Historically, 59% of months were positive and 41% were negative. The best month was Dec 2023 with a return of +14.3%, while the worst month was Dec 2024 at -9.9%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.
On a daily basis, HRTS closed higher 51% of trading days. The best single day was Apr 9, 2025 with a return of +4.4%, while the worst single day was Apr 4, 2025 at -6.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.80% | 1.46% | -6.67% | -0.09% | 1.99% | -3.53% | -6.17% | ||||||
| 2025 | 5.40% | 1.15% | -4.71% | -0.44% | -4.86% | 2.88% | -2.55% | 6.14% | 4.69% | 5.27% | 10.16% | -0.30% | 23.93% |
| 2024 | 2.17% | 8.17% | 1.03% | -8.54% | 2.11% | 4.45% | 2.73% | 3.18% | -4.92% | -2.89% | -0.40% | -9.87% | -4.30% |
| 2023 | 0.62% | 14.26% | 14.97% |
Benchmark Metrics
Tema Obesity & Cardiometabolic ETF has an annualized alpha of -3.43%, beta of 0.69, and R2 of 0.31 versus S&P 500 Index. Calculated based on daily prices since November 22, 2023.
- This ETF participated in 136.75% of S&P 500 Index downside but only 73.44% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.69 may look defensive, but with R2 of 0.31 this ETF is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this ETF's risk.
- R2 of 0.31 means the benchmark explains less than half of this ETF's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -3.43%
- Beta
- 0.69
- R²
- 0.31
- Upside Capture
- 73.44%
- Downside Capture
- 136.75%
Expense Ratio
HRTS has an expense ratio of 0.75%, placing it in the medium range.
Return for Risk
Risk / Return Rank
HRTS ranks 33 for risk / return — below 33% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and compare them to S&P 500 Index.
| HRTS | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.25 | 2.39 | -1.13 |
Sortino ratioReturn per unit of downside risk | 1.91 | 3.25 | -1.34 |
Omega ratioGain probability vs. loss probability | 1.22 | 1.43 | -0.22 |
Calmar ratioReturn relative to maximum drawdown | 1.83 | 3.11 | -1.29 |
Martin ratioReturn relative to average drawdown | 4.65 | 14.38 | -9.73 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Tema Obesity & Cardiometabolic ETF provided a 1.43% dividend yield over the last twelve months, with an annual payout of $0.47 per share.
| Period | TTM | 2025 | 2024 |
|---|---|---|---|
| Dividend | $0.47 | $0.47 | $0.47 |
Dividend yield | 1.43% | 1.34% | 1.63% |
Monthly Dividends
The table displays the monthly dividend distributions for Tema Obesity & Cardiometabolic ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | $0.47 |
| 2024 | $0.47 | $0.47 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Tema Obesity & Cardiometabolic ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tema Obesity & Cardiometabolic ETF was 25.81%, occurring on Apr 8, 2025. Recovery took 160 trading sessions.
The current Tema Obesity & Cardiometabolic ETF drawdown is 9.59%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -25.81%Apr 2025 | 8mo 25d | 7mo 21d | 1y 4moJul 2024 - Nov 2025 |
2024 correction2024 | -11.72%Apr 2024 | 1mo 16d | 2mo 23d | 4mo 9dMar 2024 - Jul 2024 |
2026 correction2026 | -11.01%Mar 2026 | 2mo 18d | — | 4mo 26dJan 2026 - now |
2025 pullback2025 | -4.13%Dec 2025 | 11d | 15d | 26dNov 2025 - Dec 2025 |
2024 pullback2024 | -3.35%Jan 2024 | 8d | 11d | 19dJan 2024 - Jan 2024 |
Drawdown Indicators
| HRTS | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.81% | -56.78% | +30.97% |
Max Drawdown (1Y)Largest decline over 1 year | -11.01% | -9.10% | -1.91% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -9.59% | 0.00% | -9.59% |
Average DrawdownAverage peak-to-trough decline | -9.02% | -10.72% | +1.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.32% | 1.97% | +2.35% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with HRTS
Add Tema Obesity & Cardiometabolic ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with HRTS